No Data
BTIG Maintains Akoya Biosciences(AKYA.US) With Buy Rating, Maintains Target Price $6
BTIG analyst Mark Massaro maintains $Akoya Biosciences(AKYA.US)$ with a buy rating, and maintains the target price at $6.According to TipRanks data, the analyst has a success rate of 30.8% and a
Akoya Biosciences: Poised for Recovery and Growth Amidst Market Challenges
Akoya Biosciences to Report Second Quarter 2024 Financial Results on August 5, 2024, and Participate at Two Upcoming Investor Conferences
MARLBOROUGH, Mass., July 15, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (NASDAQ:AKYA) ("Akoya"), The Spatial Biology Company, today announced that it will release financial results for the second quarter of
While Institutions Own 21% of Akoya Biosciences, Inc. (NASDAQ:AKYA), Private Equity Firms Are Its Largest Shareholders With 49% Ownership
CCORF Maintains Akoya Biosciences(AKYA.US) With Buy Rating, Maintains Target Price $6
CCORF analyst Kyle Mikson CFA maintains $Akoya Biosciences(AKYA.US)$ with a buy rating, and maintains the target price at $6.According to TipRanks data, the analyst has a success rate of 24.8% and a t
Craig-Hallum Initiates Akoya Biosciences(AKYA.US) With Buy Rating, Announces Target Price $7.5
Craig-Hallum analyst William Bonello initiates coverage on $Akoya Biosciences(AKYA.US)$ with a buy rating, and sets the target price at $7.5.According to TipRanks data, the analyst has a success rate